A tumour control probability model for radiotherapy of prostate cancer using magnetic resonance imaging-based apparent diffusion coefficient maps
Author:
Funder
European Commission
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference35 articles.
1. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines;Delaney;Cancer,2005
2. Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison;Leborgne;Int J Radiat Oncol Biol Phys,2009
3. Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy;Valdagni;Radiother Oncol,2005
4. Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation;Nguyen;Cancer,2013
5. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling;Peeters;Int J Radiat Oncol Biol Phys,2006
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Data Science Opportunities To Improve Radiotherapy Planning and Clinical Decision Making;Seminars in Radiation Oncology;2024-10
2. Introducing new plan evaluation indices for prostate dose painting IMRT plans based on apparent diffusion coefficient images;Radiation Oncology;2022-11-23
3. Introducing new plan evaluation indices for prostate dose painting IMRT plans based on apparent diffusion coefficient images;2022-08-04
4. Magnetic resonance imaging‐only‐based radiation treatment planning for simultaneous integrated boost of multiparametric magnetic resonance imaging‐defined dominant intraprostatic lesions;Precision Radiation Oncology;2022-04-19
5. Medical Imaging Biomarker Discovery and Integration Towards AI-Based Personalized Radiotherapy;Frontiers in Oncology;2022-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3